Prompt

Outline the pharmacology of vecuronium, explaining why it has historically been favoured for cardiac anaesthesia, and how it differs from rocuronium and atracurium.

Question

Outline the pharmacology of vecuronium, explaining why it has historically been favoured for cardiac anaesthesia, and how it differs from rocuronium and atracurium.

References10Show

[1]Bowman WC Neuromuscular block. Br J Pharmacol, 2006.PMID 16402115
[2]Segredo V, Caldwell JE, Matthay MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med, 1992.PMID 1353252
[3]Segredo V, Shin YS, Sharma ML, et al. Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats. Anesthesiology, 1991.PMID 1675040
[5]Tacquard C, Serrier J, Viville S, et al. Epidemiology of perioperative anaphylaxis in France in 2017-2018: the 11th GERAP survey. Br J Anaesth, 2024.PMID 38493055
[7]Krönauer T, Girrbach F, Simon P, et al. [Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice]. Die Anaesthesiologie, 2026.PMID 42334564
[8]Staals LM, van Egmond J, Driessen JJ, et al. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey. Eur J Anaesthesiol, 2011.PMID 21157358
[9]Sun Pharmaceutical Industries, Inc. VECURONIUM BROMIDE injection, powder, lyophilized, for solution — prescribing information. DailyMed, 2026.Source
[10]Hospira, Inc. ATRACURIUM BESYLATE injection, solution — prescribing information. DailyMed, 2023.Source
[11]Baxter Healthcare Corporation ROCURONIUM BROMIDE injection, solution — prescribing information. DailyMed, 2026.Source
[12]Shandong New Time Pharmaceutical Co., Ltd. SUGAMMADEX injection, solution — prescribing information. DailyMed, 2026.Source

Question

Outline the pharmacology of vecuronium, explaining why it has historically been favoured for cardiac anaesthesia, and how it differs from rocuronium and atracurium.

References10Show

[1]Bowman WC Neuromuscular block. Br J Pharmacol, 2006.PMID 16402115
[2]Segredo V, Caldwell JE, Matthay MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med, 1992.PMID 1353252
[3]Segredo V, Shin YS, Sharma ML, et al. Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats. Anesthesiology, 1991.PMID 1675040
[5]Tacquard C, Serrier J, Viville S, et al. Epidemiology of perioperative anaphylaxis in France in 2017-2018: the 11th GERAP survey. Br J Anaesth, 2024.PMID 38493055
[7]Krönauer T, Girrbach F, Simon P, et al. [Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice]. Die Anaesthesiologie, 2026.PMID 42334564
[8]Staals LM, van Egmond J, Driessen JJ, et al. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey. Eur J Anaesthesiol, 2011.PMID 21157358
[9]Sun Pharmaceutical Industries, Inc. VECURONIUM BROMIDE injection, powder, lyophilized, for solution — prescribing information. DailyMed, 2026.Source
[10]Hospira, Inc. ATRACURIUM BESYLATE injection, solution — prescribing information. DailyMed, 2023.Source
[11]Baxter Healthcare Corporation ROCURONIUM BROMIDE injection, solution — prescribing information. DailyMed, 2026.Source
[12]Shandong New Time Pharmaceutical Co., Ltd. SUGAMMADEX injection, solution — prescribing information. DailyMed, 2026.Source

Vecuronium pharmacology and reversal

Question

Vecuronium pharmacology and reversal

Question